Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancer.
- DOI
- 10.1002/1878-0261.70264
- Published
- 2026 May 21
- Container
- Molecular oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/1878-0261.70264,
title = {Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancer.},
author = {Nishimura J and Kuribayashi T and Brägelmann J and Okawa S and Taoka M and Mori S and Nishimura T and Tanaka T and Makimoto G and Ninomiya K and Rai K and Ichihara E and Katayama R and Hotta K and Tabata M and Togashi Y and Maeda Y and Sos ML and Kiura K and Ohashi K},
year = {2026},
journal = {Molecular oncology},
doi = {10.1002/1878-0261.70264},
url = {https://doi.org/10.1002/1878-0261.70264}
}RIS
TY - JOUR TI - Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancer. AU - Nishimura J AU - Kuribayashi T AU - Brägelmann J AU - Okawa S AU - Taoka M AU - Mori S AU - Nishimura T AU - Tanaka T AU - Makimoto G AU - Ninomiya K AU - Rai K AU - Ichihara E AU - Katayama R AU - Hotta K AU - Tabata M AU - Togashi Y AU - Maeda Y AU - Sos ML AU - Kiura K AU - Ohashi K PY - 2026 JO - Molecular oncology DO - 10.1002/1878-0261.70264 UR - https://doi.org/10.1002/1878-0261.70264 ER -
APA
J, N., T, K., J, B., S, O., M, T., S, M., T, N., T, T., G, M., K, N., K, R., E, I., R, K., K, H., M, T., Y, T., Y, M., ML, S., K, K., & K, O. (2026). Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancer.. Molecular oncology. https://doi.org/10.1002/1878-0261.70264
Source records
- pubmed · retrieved 2026-09-26T19:35:34.035Z